Hippocampal volume and verbal memory performance in late-stage bipolar disorder.

J Psychiatr Res

UT Center of Excellence on Mood Disorder, Department of Psychiatry and Behavioral Sciences, The University of Texas Science Center at Houston, Houston, TX, USA.

Published: February 2016

Studies about changes in hippocampal volumes in subjects with bipolar disorder (BD) have been contradictory. Since the number of manic episodes and hospitalization has been associated with brain changes and poor cognitive outcomes among BD patients, we have hypothesized that these variables could clarify this issue. We stratified subjects with BD in early (BD-Early), intermediate (BD-intermediate) and late (BD-Late) stages as a function of number of manic episodes and prior hospitalization. Then, we compared their hippocampal volumes and California Verbal Learning Test-II (CVLT-II) scores with healthy controls (HC) using the general linear model. A total of 173 subjects were included in the study (112 HC, 15 BD-Early, 30 BD-Intermediate, and 16 BD-Late). We found a significant group effect on hippocampus volume (F(3,167) = 3.227, p = 0.024). Post-hoc analysis showed that BD-Late subjects had smaller hippocampus than HC (p = 0.017). BD-Early and BD-Intermediate subjects showed no significant difference in hippocampus volume compared to HC and BD-Late subjects. The CVLT trial 1 to 5 scores were significantly different across the groups (F(3,167) = 6.371, p < 0.001). Post-hoc analysis showed that BD-Intermediate (p = 0.006) and BD-Late (p = 0.017) subjects had worse memory performance during immediate recall than HC, while the performance difference between BD-Early subjects and HC was not significant (p = 0.208). These findings add to the notion that BD is a neuroprogressive disorder with brain changes and cognitive impairment according to prior morbidity (number of manic episodes and hospitalization). Also, they suggest that hippocampus is a brain marker and a potential therapeutic target for patients at late stage.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985176PMC
http://dx.doi.org/10.1016/j.jpsychires.2015.12.012DOI Listing

Publication Analysis

Top Keywords

number manic
12
manic episodes
12
memory performance
8
bipolar disorder
8
hippocampal volumes
8
subjects
8
episodes hospitalization
8
brain changes
8
bd-early bd-intermediate
8
hippocampus volume
8

Similar Publications

Bipolar disorder in patients with psoriasis, and the impact of lithium therapy on psoriasis.

Clin Dermatol

January 2025

Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, RI, USA; GK Dermatology PC, South Weymouth, MA, USA. Electronic address:

Article Synopsis
  • Research shows a connection between psoriasis and bipolar disorder (BD), with limited studies specifically addressing the link.
  • The review analyzed various studies involving BD patients, lithium's effects on psoriasis, and found that psoriasis may increase the risk of developing BD.
  • Lithium therapy might worsen psoriasis symptoms, but inositol supplementation could potentially alleviate these effects, highlighting the need for further investigation.
View Article and Find Full Text PDF

Background: Non-invasive brain stimulation (NIBS), such as transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), has emerged as a promising alternative in the precise treatment of clinical symptoms, such as the cognitive impairment of bipolar disorder (BD). Optimizing the neurocognitive effects by combining tDCS and rTMS to strengthen the clinical outcome is a challenging research issue.

Objective: In this randomized, controlled trial, we first combined tDCS and neuronavigated rTMS targeting the V1 region to explore the efficacy on neurocognitive function in BD patients with depressive episodes.

View Article and Find Full Text PDF

Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.

J Affect Disord

December 2024

Louis A. Faillace Department of Psychiatry & Behavioral Sciences, University of Texas Health Science Center at Houston, 1941 East Rd, Houston, TX 77054, USA. Electronic address:

Psychedelic substances such as psilocybin have recently gained attention for their potential therapeutic benefits in treating depression and other mental health problems. However, individuals with bipolar disorder (BD) have been excluded from most clinical trials due to concerns about manic switches or psychosis. This study aimed to systematically examine the effects of recreational psychedelic use in individuals with BD.

View Article and Find Full Text PDF

Background: Little information is available on response to electroconvulsive therapy (ECT) in patients with bipolar disorder (BD) from India.

Aim: This exploratory study aims to evaluate and compare the sociodemographic and clinical profiles, treatment outcomes of BD patients with depression and mania/mixed episode who received ECT and to evaluate the predictors of response to ECT.

Results: Data of 278 BD patients who received 325 ECT courses were extracted from the ECT register.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how users with bipolar disorder self-induce mania or hypomania by examining online forum posts, revealing a variety of methods reported among participants.
  • Findings indicate that common methods include reducing sleep, increasing caffeine intake, and stopping medication, with the primary motivation being to alleviate depressive episodes.
  • The research highlights the importance of online discussions as a resource for understanding mania triggers and stresses the responsible nature of many postings, which often advise against self-induction practices.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!